PDF
ePub
Citation
Print
Abstract
Objectives
Here the author report the mid-term clinical outcomes analysis with efficacy and safety of HoLEP.
Methods
From May 2010 to September 2012, 270 consecutive patients treated with HoLEP were enrolled in this study. All patients was evaluated by digital rectal examination (DRE), transrectal ultrasonography (TRUS), serum PSA preoperatively. International Prostate Symptom Score (IPSS), peak urinary flow rate (Qmax), and postvoid residual urine (PVR) were documented preoperatively and 1, 3, 6, 12, 24 months postoperatively. The perioperative data and complications were analyzed. All procedures of HoLEP was done by a single surgeon.
Results
The mean patient age at the surgery was 67.5 years (45-82), and the mean PSA was 3.7 ng/mL (0.4-19.4). Mean operation time was 73.6 minutes (30-150). Mean prostate volume was 64.3 mL (20-150) and mean resected tisssue weight was 9.3 g (2-63). Mean catheter indwelling time was 2.7 day (1-6), and mean hospital stay was 3.2 day (1-7). The blood loss was minimal, so transfusion was not needed. The baseline data were IPSS; 23.0 (7-35), QoL score; 5.4 (4-6), Qmax (mL/s); 12.5 (1.2-16.5), PVR (mL); 59 (20-250). Postoperatively, IPSS and QoL scores and PVR decreased, and Qmax increased significantly. Intraoperative complication was minor capsular perforation (n = 5). Postoperative complications were acute urinary retention (n = 9), transient incontinence (n = 17), urinary tract infection (n=4), urethral stricture (n=4) and bladder neck contracture (n = 12).
REFERENCES
1.Kuo RL., Paterson RF., Kim SC., Siqueira Jr TM., Elhilali MM., Lingeman JE. Holmium laser enucleation of the prostate (HoLEP): A technical update. World J Surg Oncol. 2003. 1:6–14.
2.Shah HN., Sodha HS., Kharodawala SJ., Khandkar AA., Hegde SS., Bansal MB. Influence of prostate size on the outcome of holmium laser enucleation of the prostate. BJU Int. 2008. 101:1536–41.
3.Moody JA., Lingeman JE. Holmium laser enucleation for prostate adenoma greater than 100 gmL comparison to open prostatectomy. J Urol. 2001. 165:459–62.
4.Gilling PJ., Fraundorfer MR. Holmium laser prostatectomy: a technique in evolution. Curr Opin Urol. 1998. 8:11–5.
5.Kuntz RM., Ahyai SA., Lehrich K., Fayad A. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate; a randomized prospective trial in 200 patients. J Urol. 2004. 172:1012–6.
6.Kuntz RM., Lehrich K., Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. EurUrol. 2008. 53:160–6.
7.Costello AJ., Bowsher WG., Bolton DM., Braslis KG., Burt J. Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol. 1992. 69:603–8.
8.Ruszat R., Seitz M., Wyler SF., Muller G., Rieken M., Bonkat G, et al. Prospective single centre comparison of 120 W diode pumped solid state high intensity system laser vaporization of the prostate and 200 W high intensive diode laser ablation of the prostate for treating benign prostatic hyperplasia. BJU Int. 2009. 104:820–5.
9.Te AE., Malloy TR., Stein BS., Ulchaker JC., Nseyo UO., Hai MA, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol. 2004. 172:1404–8.
10.Bachmann A., Ruszat R., Wyler S., Reich O., Seifert HH., Muller A, et al. Photoselective vaporization of the prostate: the basel experience after 108 procedures. Eur Urol. 2005. 47:798–804.
11.Lerner LB., Tyson MD. Holmium laser applications of the prostate. UrolClin North Am. 2009. 36:485–95.
12.Matlaga BR., Kim SC., Kuo RL., Watkins SL., Lingeman JE. Holmium laser enucleation of the prostate of > 125 mL. BJU Int. 2006. 97:81–4.
13.Kuo RL., Kim SC., Lingeman JE., Paterson RF., Watkins SL., Simmons GR, et al. Holmium laser enucleation of the prostate (HoLEP): the Methodist Hospital experience with greater than 75 gm enucleation. J Urol. 2003. 170:149–52.
14.Naspro R., Bachmann A., Gilling P., Kuntz R., Madersbacher S., Montorsi F, et al. A review of the recent evidence (2006-2008) for 532-nm photoselective laser vaporization and holmium laser enucleation of the prostate. Eur Urol. 2009. 55:1345–57.
15.Tyson MD., Lerner LB. Safety of holmium laser enucleation of the prostate in anticoagulated patients. J Endourol. 2009. 23:1343–6.
16.Elzayat E., Habib E., Elhilali M. Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol. 2006. 175:1428–32.
17.Kim SC., Tinmouth WW., Kuo RL., Paterson RF., Lingerman JE. Simultaneous holmium laser enucleation of the prostate and upper-tract endourologic stone procedures. J Endourol. 2004. 18:971–5.
18.Abdel-Hakim AM., Habib EI., El-Feel AS., Elbaz AG., Fayad AM., Abdel-Hakim MA, et al. Holmium laser enucleation of the prostate: initial report of the first 230 Egyptian cases performed in a single center. Urology. 2010. 76:448–52.
19.Peterson MD., Matlaga BR., Kim SC., Kuo RL., Soergel TM., Watkins SL, et al. Holmium laser enucleation of the prostate for men with urinary retention. J Urol. 2005. 174:998–1001.
20.Shah HN., Mahajan AP., Sodha HS., Hegde SS., Mohile PD., Bansal MB. Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol. 2007. 177:1468–74.
21.Shah HN., Mahajan AP., Hegde SS., Bansal MB. Peri-operative complications of holmium laser enucleation of the prostate: experience in the first 280 patients, and a review of literature. BJU Int. 2007. 100:94–101.
22.Vavassori I., Valenti S., Naspro R., Vismara A., Dell'Acqua V., Manzetti A, et al. Three-year outcome following holmium laser enucleation of the prostate combined with mechanical morcellation in 330 consecutive patients. Eur Urol. 2008. 53:599–604.
23.Seki N., Mochida O., Kinukawa N., Sagiyama K., Naito S. Holmium laser enucleation for prostatic adenoma: analysis of learning curve over the course of 70 consecutive cases. J Urol. 2003. 170:1847–50.
24.Tan AH., Gilling PJ., Kennet KM., Frampton C., Westenberg AM., Fraundorfer MR. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol. 2003. 170:1270–4.
25.Kuo RL., Paterson RF., Siqueira TM Jr., Watkins SL., Simmons GR., Steele RE, et al. Holmium laser enucleation of the prostate: morbidity in a series of 206 patients. Urology. 2003. 62:59–63.
26.Takiuchi H., Nakao A., Ihara H. Prevention of transient urinary incontinence in peri-operative period of modified holmium laser enucleation of the prostate (HoLEP). Hinokika Kiyo. 2008. 54:475–8.
27.Du C., Jin X., Bai F., Qiu Y. Holmium laser enucleation of the prostate: the safety, efficacy, and learning experience in China. J Endourol. 2008. 22:1031–6.
28.Jeong CW., Oh JK., Cho MC., Bae JB., O SJ. Enucleation ratio efficacy might be a better predictor to assess learning curve of holmium laser enucleation of the prostate. Int Braz J Urol. 2012. 38:362–72.
Table 1.
Baseline characteristics of the 270 patients who underwent HoLEP
Table 2.
Changes in clinical parameters after HoLEP
XML Download